|
Volumn 82, Issue 10, 1995, Pages 1414-1420
|
Randomized, double‐blind phase II trial of Lexipafant, a platelet‐activating factor antagonist, in human acute pancreatitis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
LEXIPAFANT;
PLACEBO;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
ACUTE PANCREATITIS;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ACUTE DISEASE;
ADULT;
AGED;
AGED, 80 AND OVER;
AMYLASES;
C-REACTIVE PROTEIN;
DOUBLE-BLIND METHOD;
E-SELECTIN;
FEMALE;
HUMANS;
INTERLEUKIN-6;
INTERLEUKIN-8;
LIPASE;
MALE;
MIDDLE AGED;
PANCREATITIS;
PLATELET ACTIVATING FACTOR;
|
EID: 0028876181
PISSN: 00071323
EISSN: 13652168
Source Type: Journal
DOI: 10.1002/bjs.1800821039 Document Type: Article |
Times cited : (225)
|
References (53)
|